USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Laila Nutraceuticals

USPTO PatentsView assignee record - 27 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Laila ranks #11,321 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 9 technology areas.

#11,321
of 49,997 US assignees by volume
Top 30%
by Innovation Score (42.8/100)
16.9
avg claims per patent
+25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11321 · Foreign Corporation #11,321 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 27 grants
  • UPPER-Q #11,321/49,997
  • PHOTO-FINISH Korea Photonics…
  • CPC-NARROW A61K · 9 areas
  • INNOV-PAR 42.8/100
  • CLAIMS-RICH 16.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +25% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Korea Photonics Technology Institute (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Laila’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Laila

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Laila's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Laila?

Each dot is one of Laila’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Laila’s own 16.9 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Laila vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 26.92727.1 0510152025 Granted patents (volume) Avg claims / patent Korea Photonics Technology Institute - 27, 9.67Korea Photonics T…Kraus USA Plumbing LLC - 27, 5.44Kraus USA PlumbingLaboratoires Bodycad Inc. - 27, 15.74Laboratoires Body…Laboratorios Farmaceuticos Rovi, S.A. - 27, 23.07Laboratorios Farm…Lekisport AG - 27, 22.89LekisportLEM International SA - 27, 14.59LEM InternationalLiebherr-hydraulikbagger GMBH - 27, 13.22Liebherr-hydrauli…Lightwave Logic, Inc. - 27, 13.59Lightwave LogicLaila Nutraceuticals - 27, 16.93Laila Nutraceutic…
Laila vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Laila's grants concentrate

Laila Nutraceuticals is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (6 grants) versus a trough of 1 in 2015. By volume, Laila sits between Korea Photonics Technology Institute and Lightwave Logic, Inc..

Laila's three-year grant acceleration

Laila Nutraceuticals shows 11 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Laila's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Laila holds 27 patents at rank #11,319, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Laila

By rank, the assignees closest to #11,319 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Laila's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Laila, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Laila ranks #847 of 7,163 assignees by patent count in that subclass.

Laila's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018201920202021202220232024 6
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Laila Nutraceuticals patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 3.7%
2016 5 18.5%
2017 1 3.7%
2018 2 7.4%
2019 3 11.1%
2020 1 3.7%
2021 3 11.1%
2022 1 3.7%
2023 4 14.8%
2024 6 22.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Laila Nutraceuticals's patent record in context - here's where to go next.

  • Laila Nutraceuticals's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #11,321 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Laila Nutraceuticals against Korea Photonics Technology Institute, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.